Mapping genes for NIDDM: Design of the Finland-United States investigation of NIDDM genetics (FUSION) study

Diabetes Care

Volumn 21, Issue 6, 1998, Pages 949-958

  Valle, Timo ^a   Tuomilehto, Jaakko ^a   Bergman, Richard N ^b   Ghosh, Soumitra ^d   Hauser, Elizabeth R ^e   Eriksson, Johan ^a   Nylund, Stella J ^a,d   Kohtamåki, Kimmo ^a   Toivanen, Liisa ^a   Vidgren, Gabriele ^a   Tuomilehto Wolf, Eva ^a   Ehnholm, Christian ^a   Blaschak, Jillian ^e   Langefeld, Carl D ^e   Watanabe, Richard M ^b,e   Magnuson, Victoria ^d   Ally, Delphine S ^d   Hagopian, William A ^f   Ross, Edna ^b   Buchanan, Thomas A ^c   Collins, Francis ^d   Boehnke, Michael ^e   more..

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC GROUP; FINLAND; GENE MAPPING; GENETIC LINKAGE; HUMAN; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; UNITED STATES;

AGE OF ONSET; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; NUCLEAR FAMILY; PHENOTYPE; QUANTITATIVE TRAIT, HERITABLE; SEX CHARACTERISTICS; UNITED STATES;

EID: 3643136390     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.6.949     Document Type: Article

References (81)

1. King H, Rewers M: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults: WHO Ad Hoc Diabetes Reporting Group, Diabetes Care 16:157-177, 1993
2. Pincus G, White P: On the inheritance of diabetes mellitus. I. An analysis of 675 family histories. Am J Med Sci 186:1-14, 1933
3. Cammidge PJ: Heredity as a factor in the aetiology of diabetes mellitus. Lancet i:393-395, 1934
4. Hanhart E: Neue Beiträge zur Kenntnis der Vererbung des diabetes mellitus, Helv Med Acta 14:243-262, 1947
5. Harris H: The familial distribution of diabetes mellitus: a study of the relatives of 1241 diabetic propositi. Ann Eugenics 15:95-119, 1950
6. Barnett AH, Eff C, Leslie RDG, Pyke DA: Diabetes in identical twins: a study of 200 pairs. Diobetologia 20:87-93, 1981
7. Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD: Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30:763-768, 1987
8. Lo SS, Tun RY, Hawa M, Leslie RD: Studies of diabetic twins. Diabetes Metab Rev 7:223-238, 1991
9. Kaprio J, Tuomilehto j, Koskenvub M, Romanov K, Reunanen A, Eriksson J, Stengård J, Kesäniemi YA: Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus if in a population-based cohort of twins in Finland. Diabetologia 35:1060-1067, 1992
10. Rich SS: Mapping genes in diabetes: genetic epidemiological perspective. Diabetes 39:1315-1319, 1993
11. Ghosh S, Schork NJ: Genetic analysis of NIDDM: the study of quantitative traits. Diabetes 45:1-14, 1996
12. Leslie RDG, Volkmann HP, Pencher M, Hanning I, Orskov H, Alberti KGMM: Metabolic abnormalities in children of noninsulin dependent diabetics. Br Med J 293:840-842, 1986
13. Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC: Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes 37:622-628, 1988
14. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbot WGH, Knowler WC, Bennett PH, Moll P, Bogardus C: In vivo insulin action is a familial characteristic in nondiabetic Pima Indians. Diabetes 36:1329-1335, 1987
15. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337- 343, 1989
16. Thomas F, Balkau B, Vauzelle-Kervroedan F, Papoz L: Maternal effect and familial aggregation in NIDDM: the CODIAB Study: COD1AB-INSERM-ZENECA Study Group. Diabetes 43:63-67, 1994
17. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329:1988-1992, 1993
18. Mitchell BD, Kammerer CM, Reinhart LJ, Stern MP: NIDDM in Mexican-American families: heterogeneity by age of onset. Diabetes Care 17:567-573, 1994
19. Strandberg TE, Tilvis RS, Lindberg O, Valvanne J, Sairanen S, Ehnholm C, Tuomilehto J: High plasma insulin associates with lower LDL cholesterol in elderly individuals. Atherosclerosis 121:267-273, 1996
20. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
21. Bergman RN, Yang YJ, Hope ID, Ader M: The role of the transcapillary insulin transport in the efficiency of insulin action: studies with glucose clamps and the minimal model. Horm Metab Res 24:49-56, 1990
22. Bergman RN: Toward physiological understanding of glucose tolerance: minimalmodel approach. Diabetes 38:1512-1527, 1989
23. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr: Diminished B cell secretory capacity in patients with non-insulindependent diabetes mellitus. J Clin Invest 74:1318-1328, 1984
24. Herbert V Law K, Gottlieb C, Bleicher S: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965
25. Hagopian WA, Karlsen AE, Gottsäter A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyberg T, Lernmark A: Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 91:368-374, 1993
26. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J, Lernmark A: Glutamate decarboxylase-, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general populationbased study of Swedish children. J Clin Invest 95:1505-1511, 1995
27. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC: High level of concordance between assays for glutamic acid decarboxylase antibodies: the First International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes 43:1005-1009, 1994
28. Jaffe M: Über den Niederschlag, welchen Pikrinsäure in normalem Ham erzeugt und über eine neue Reaction des Kreatinins. Z Physiol Chem 10:391-400, 1886
29. Gerbaut T: Immunoturbidimetry of albumin in serum, cerebrospinal fluid, and urine with a unique calibration curve (Abstract). Clin Chem 33:1260-1261, 1987
30. Ghosh S, Karanjawala ZE, Hauser ER, Ally D, Knapp JI, Rayman JB, Musick A, Tannenbaum J, Te C, Shapiro S, Eklridge W, Musick T, Martin C, Smith JR, Carpten JD, Brownstein MJ, Powell JI, Whiten R, Chines P, Nylund SJ, Magnuson VM, Boehnke M, Collins FS, the FUSION Study Group: Methods for precise sizing, automated binning of alleles and reduction of error rates in large-scale genotyping using fluorescently labeled dinucleotide markers. Genome Res 7:165-178, 1997
31. Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R, the DIME Study Group: New susceptibility haplotype for type 1 diabetes. Lancet ii:299-302, 1989
32. Hauser ER, Boehnke M, Guo SW, Risch N: Affected-sib-pair interval mapping and exclusion for complex genetic traits: sampling considerations. Genetic Epidemiol 13:117-137, 1996
33. Risch N: Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46:229-241, 1990
34. Kruglyak L, Lander ES: Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet 57:439-454, 1995
35. Haseman JK, Elston RC: The investigation of linkage between a quantitative trait and a marker locus. Behav Genet 2:3-19, 1972
36. Amos CI, Zhu DK, Boerwinkle E: Assessing genetic linkage and association with robust components of variance. Ann Hum Genet 60:143-160, 1996
37. Valle T, Reunanen A, Koivisto V, Kangas T, Rissanen A: The glycemie control in patients with diabetes in Finland (Abstract). Diabetologia 39 (Suppl. 1):A28, 1996
38. Hanis CL, Boerwinkle E, Chakraborty R, Ellworth DL, Concannon P, Stirling B, Morrison VA, Wapelhorst B, Spielman RS, Gogolin-Ewens KJ, Shepard JM, Williams SR, Risch N, Hinds D, Iwasaki N, Ogata M, Omori Y, Petzold C, Rietzsch H, Schröder HE, Schulze J, Cox NJ, Menzel S, Boriraj VV, Chen X, Lim LR, Lindner T, Mereu LE, Wang YQ, Xiang K, Yamagata K, Yang Y, Bell GI: A genome-wide search for human noninsulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13:161-166, 1996
39. Mahtani MM, Widen E, Lehto M, Thomas J, McCarthy M, Brayer J, Bryant B, Chan G, Daly M, Forsblom C, Kanninen T, Kirby A, Kruglyak L, Munnelly K, Parkkonen M, Reeve-Daly MR Weaver A, Brettin T, Duyk G, Lander ES, Groop LC: Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 14:90-94, 1996
40. Stern MP, Duggirala R, Mitchell BD, Reinhart LJ, Shivakumar S, Shipman PA, Uresandi OC, Benavides E, Blangero J, O'Connell P: Evidence for linkage of regions on chromosomes 6 and 11 to plasma concentrations in Mexican Americans. Genome Res 6:724-634, 1996
41. Thompson DB, Janssen RC, Ossowski VM, Prochazka M, Knowler WC, Bogardus C: Evidence of linkage between a region on chromosome Ip and the acute insulin response in Pima Indians. Diabetes 44:478-481, 1995
42. Raffel LJ, Robbins DC, Norris JM, Boerwinkle E, DeFronzo RA, Elbein SC, Fujimoto W, Hanis CL, Kahn SE, Permutt MA, Chiu KC, Cruz J, Ehrmann DA, Robertson RP, Rotter JI, Buse J: The GENNID Study: a resource for mapping the genes that cause NIDDM. Diabetes Care 19:864-872, 1996
43. de la Chapelle A: Disease gene mapping in isolated human populations: the example of Finland. J Med Genet 30:857-865, 1993
44. Sajantila A, Salem AH, Savolainen P, Bauer K, Gierig C, Pääbo S: Patemal and maternal DNA lineages reveal a bottleneck in the founding of the Finnish population. Proc Natl Acad Sci USA 93:12035-12039, 1996
45. Nevanlinna HR: The Finnish population structure: a genetic and genealogical study Hereditas 71:195-236, 1972
46. Hästbacka J, de la Chapelle A, Kaitila I, Sistonen P, Weaver A, Lander E: Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet 2:204-211, 1993
47. Ikonen E, Baumann M, Grön K, Syvänen AC, Enomaa N, Halila R, Aula P, Peltonen L: Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutaiion causing the disease. EMBOJ 10:51-58, 1991
48. Kestilä M, Männikkö M, Holmberg C, Gyapay G, Weissenbach J, Savolainen ER, Peltonen L, Tryggvason K: Congenital nephrotic syndrome of the Finnish type maps to the long ami of chromosome 19. Am J Hum Gen 54:757-764, 1994
49. Valle T, Tuomilehto J, Eriksson J: Epidemiology of NIDDM in Europids. In International Textbook of Diabetes Mellitus. 2nd ed. Alberti KGMM, Zimmet P, DeFronzo RA, Keen H, Eds. Chichester, U.K., Wiley, 1997,p. 125-142
50. Tuomilehto-Wolf E, Tuomilehto J, Hitman G, Nissinen A, Stengård J, Pekkanen J, Kivinen P, Kaarsalo E, Karvonen M: Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region. BMJ 307:155-159, 1993
51. Groop LC, Kankuri M, Schalin-Jäntti C, Ekstrand A, Nikula-Ijäs R Widen E, Kuismanen E, Eriksson J, Franssila-Kallunki A, Saloranta C: Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 328:10-14, 1993
52. McCarthy M, Hitman G, Hitchins M, Riikonen A, Stengård J, Nissinen A, TuomilehtoWolf E, Tuomilehto J: Glucokinase gene polymorphisms: a genetic marker for glucose intolerance in a cohort of elderly Finnish men, Diabet Med 11:198-204, 1994
53. Laakso M, Malkki M, Kekäläinen P, Kuusisto J, Mykkänen L, Deeb SS: Glucokinase gene variants in subjects with late-onset NIDDM and impaired glucose tolerance. Diabetes Care 18:398-400, 1995
54. Laakso M, Malkki M, Deeb SS: Amino acid substitutions in hexokinase II among patients in NIDDM. Diabetes 44:330-334, 1995
55. Laakso M, Malkki M, Kekäläinen P, Kuusisto J, Deeb SS: Polymorphism of the human hexokinase II gene: lack of association with NIDDM and insulin resistance. Diabetologia 38:617-622, 1995
56. Eriksson J, Koranyi L, Bourey R, SchalinJäntti C, Widen E, Mueckler M, Permutt AM, Groop LC: Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulinresponsive glucose transporter (GLUT-4) gene in human skeletal muscle. Diabetologia 35:143-147, 1992
57. Humphreys P, McCarthy M, Tuomilehto J, Tuomilehto-Wolf E, Stratton I, Morgan R, Rees A, Owens D, Stengård J, Nissinen A, Hitman G, Turner R, O'Rahilly S: Chromosome 4q locus associated with insulin resistance in Pima Indians: studies in three European non-insulin dependent diabetic populations. Diabetes 43:800-804, 1994
58. Baker W, Hitman G, Hawrami K, McCarthy M, Riikonen A, Tuomilehto-Wolf E, Nissinen A, Tuomilehto J, Mohan Y Viswanathan M, Snehalata C, Ramachandran A, Dowse G, Zimmet P, Serjeantson S: Apolipoprotein D gene polymorphism; a new genetic marker for type 2 (non-insulin dependent) diabetic subjects in Nauru and South India. Diabet Med 11:947-952, 1994
59. Laakso M, Malkki M, Kekäläinen P, Kuusisto J, Deeb SS: Insulin receptor substrate1 variants in non-insulin-dependent diabetesj Clin Invest 94:1141-1146, 1994
60. Hitman G, Hawrani K, McCarthy MI, Wiswanathan M, Snehalata C, Ramachandran A, Tuomilehto J, Tuomilehto-Wolf E, Nissinen A, Pedersen OB: Insulin receptor substrate-1 gene mutations in non-insulin dependent diabetes: implications for the study of polygenic disease. Diabetologia 38:481-486, 1995
61. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC: Association of a polymorphism in the beta 3-adrenergicreceptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351, 1995
62. Collins FS: Positional cloning: lets not call it reverse anymore. Nat Genet 1:3-6, 1992
63. Schork NJ, Boehnke M, TerwilligerJD, Ott J: Two-trait-locus linkage analysis: a powerful strategy for mapping complex genetic traits. Am J Hum Genet 53:1127-1136, 1993
64. Eriksson J, Forsen B, Häggblom M, Teppo AM, Groop L: Clinical and metabolic characteristics of type 1 and type 2 diabetes: an epidemiological study from the Närpes community in Western Finland. Dtabet Med 9:654-660, 1992
65. Niskanen L, Karjalainen J, Siitonen O, Uusitupa M: Metabolic evolution of type 2 diabetes: a 10-year follow-up from the time of diagnosis. J Intern Med 236:263-270, 1994
66. Yki-Järvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Ryysy L, Sab S, Seppälä P, Tulokas T, Viikari J, Karjalainen J, Taskinen MR: Comparison of insulin regimens in patients with noninsulin-dependent diabetes mellitus. N Engl J Med 327:1426-1433, 1992
67. Harris MI, Robbins DC: Prevalence of adult-onset IDDM in the U.S. population. Diabetes Care 17:1337-1340, 1994
68. Mayrhofer M, Rabin DU, Messenger L, Standl E, Ziegler AG: Value of 1CA512 antibodies for prediction and diagnosis of type 1 diabetes. Exp Clin Endocrinol Diabetes 104:228-234, 1996
69. Mykkanen L, Laakso M, Uusitupa M, Pyörälä K: Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 13:1099-1105, 1990
70. Tuomilehto J, Korhonen HJ, Kartovaara L, Salomaa V, Stengård JH, Pitkänen M, Aro A, Javela K, Uusitupa M, Pitkäniemi J: Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland. Int J Epidemiol 20:1010-1017, 1991
71. Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and B-cell glucose sensitivity from the response to intravenous glucose, J Clin Invest 68:1456-1467, 1981
72. Chen M, Bergman RN, Pacini G, Porte D: Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased β-cell function. J Clin Endocrinol Metab 60:13-20, 1985
73. Kohrt WM, Kirwan JP, Staten MA, Bourey RE, King DS, Holloszy JO: Insulin resistance in aging is related to abdominal obesity. Diabetes 42:273-281, 1993
74. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U: Insulin action and age. Diabetes 45:947-953, 1996
75. Yki-Järvinen H: Role of insulin resistance in the pathogenesis of N1DDM. Diabetologia 38:1378-1388, 1995
76. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, CrapperMacLachlan DR, Alberts MJ, Hulette C, Grain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472, 1993
77. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Bamett AH, Bain SC, Todd JA: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136, 1994
78. Tuomilehto-Wolf E, Tuomilehto J, the DiMe Study Group: Is the high incidence of diabetes in young children diagnosed under the age of 4 years determined by genetic factors in Finland? Diabete Metab 19:167-172, 1993
79. Laakso M, Pyörälä K: Age of onset and type of diabetes. Diabetes Care 8:114-117, 1985
80. Cook JTE, Page RCL, O'Rahilly S, Levy J, Holman R, Barrow B, Hattersley AT, Shaw AG, Wainscoat JS, Turner RC: Availability of type II diabetic families for detection of diabetes susceptibility genes. Diabetes 42:1536-1543, 1993
81. Falk CT, Rubenstein P: Haplotype relative risks: an easy reliable way to construct a: proper control sample.for risk calculations. Ann Hum Genet 51:227-233, 1987